Access cutting-edge breast cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast cancer.
Sponsor: Oana Danciu
Check if you qualify for this breast cancer clinical trial in Birmingham, AL
If you're searching for breast cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.